United States Insomnia Market and Competitive Landscape Highlights Report 2016 - Market Advances 2010-2020 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Insomnia Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Insomnia Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Insomnia pipeline products, Insomnia epidemiology, Insomnia market valuations and forecast, Insomnia products sales and competitive landscape in the US.

The research is classified into nine sections - Insomnia overview including etiology, pathophysiology, and diagnosis, Insomnia treatment options, Insomnia pipeline products, Insomnia market analysis comprising of Insomnia epidemiology, key products marketed for Insomnia, market valuations and forecast, products sales and market shares.

Research Scope:

  • Insomnia Pipeline: Find out the products in clinical trials for the treatment of Insomnia by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Insomnia Epidemiology: Find out the number of patients diagnosed (prevalence) with Insomnia in the US
  • Insomnia Products: Identify key products marketed and prescribed for Insomnia in the US, including trade name, molecule name, and company
  • Insomnia Product Sales: Find out the sales revenues of Insomnia products, both branded and generics, in the US
  • Insomnia Market Valuations: Find out the market size for Insomnia products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Insomnia Products Market Share: Find out the market shares for key Insomnia products in the US

Key Topics Covered:

  1. Disease Overview
  2. Insomnia Treatments
  3. Insomnia Pipeline
  4. US Insomnia Epidemiology
  5. Marketed Drugs for Insomnia in US
  6. US Insomnia Market Size
  7. US Insomnia Products Sales
  8. US Insomnia Market Competitive Landscape
  9. US Insomnia Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/2r9hfh/us_insomnia

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs